NOVO HOLDINGS A/S reported 1 transaction at HEMAB THERAPEUTICS HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/6/2026ACC: 0001388325-26-000023
10% Owner
Since Apr 2026
+3.99M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
4.18M acquired · 190.03K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.18M
Price / share
—
Trade value
—
% of position
New position
5/4/2026
0.00→4.18M
Total
Net shares
+4.18M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | C · Conversion | +4.18M | — | — | New position | 0.00 | 4.18M |
| Total | +4.18M | $0.00 | ||||||
Derivative Transactions4
Series Seed Preferred Stock
Direct
Converts to
Common Stock
513.55K shares
Shares
−23.34K
Strike price
Held after
0.00
Exercisable
—
5/4/2026
Series A Preferred Stock
Direct
Converts to
Common Stock
1.58M shares
Shares
−71.87K
Strike price
Held after
0.00
Exercisable
—
5/4/2026
Series B Preferred Stock
Direct
Converts to
Common Stock
1.37M shares
Shares
−62.12K
Strike price
Held after
0.00
Exercisable
—
5/4/2026
Series C Preferred Stock
Direct
Converts to
Common Stock
719.29K shares
Shares
−32.70K
Strike price
Held after
0.00
Exercisable
—
5/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series Seed Preferred Stock Direct | Common Stock513.55K shares | 5/4/2026 | C · Conversion | −23.34K | — | 0.00 | |
| Series A Preferred Stock Direct | Common Stock1.58M shares | 5/4/2026 | C · Conversion | −71.87K | — | 0.00 | |
| Series B Preferred Stock Direct | Common Stock1.37M shares | 5/4/2026 | C · Conversion | −62.12K | — | 0.00 | |
| Series C Preferred Stock Direct | Common Stock719.29K shares | 5/4/2026 | C · Conversion | −32.70K | — | 0.00 |